Book contents
- Managing Myeloproliferative Neoplasms
- Managing Myeloproliferative Neoplasms
- Copyright page
- Contents
- Contributors
- Preface
- 1 Initial assessment of the undiagnosed patient who has an erythrocytosis, leukocytosis, or thrombocytosis
- 2 Practical approaches to molecular testing and diagnosis of mastocytosis, hypereosinophilia, and MDS/MPN overlap syndromes
- 3 Incidental splenomegaly: an approach to diagnosis
- 4 When to do a bone marrow biopsy and how to interpret it in the diagnosis of myeloproliferative neoplasm
- 5 Accurately assessing risk in your myeloproliferative neoplasm patient
- 6 Incorporating symptomatic assessment in therapy choice for patients with myeloproliferative neoplasms
- 7 The newly diagnosed patient with essential thrombocythemia
- 8 The newly diagnosed patient with polycythemia vera
- 9 Longstanding polycythemia vera and essential thrombocythemia: monitoring and management goals
- 10 Which patients are candidates for JAK inhibitors and how to manage patients on JAK inhibitor treatment
- 11 Hematopoietic cell transplantation for myelofibrosis: who and when?
- 12 Systemic mast cell disease: diagnosis and management
- 13 Hypereosinophilia: an illustrated approach to diagnosis and management
- 14 Myelodysplastic/myeloproliferative neoplasm overlap syndromes
- 15 Atypical chronic myeloid leukemia and chronic neutrophilic leukemia
- 16 Women and children with myeloproliferative neoplasms – special considerations
- 17 Conception and pregnancy in myeloproliferative neoplasms
- 18 Managing acute vascular events in patients with myeloproliferative neoplasms
- 19 Challenging thrombotic scenarios in the myeloproliferative neoplasms: splanchnic vein thrombosis and others
- 20 Familial myeloproliferative neoplasms – implications for patients and their families
- 21 Management of acute leukemia following myeloproliferative neoplasms
- Index
- References
3 - Incidental splenomegaly: an approach to diagnosis
Published online by Cambridge University Press: 05 March 2016
Book contents
- Managing Myeloproliferative Neoplasms
- Managing Myeloproliferative Neoplasms
- Copyright page
- Contents
- Contributors
- Preface
- 1 Initial assessment of the undiagnosed patient who has an erythrocytosis, leukocytosis, or thrombocytosis
- 2 Practical approaches to molecular testing and diagnosis of mastocytosis, hypereosinophilia, and MDS/MPN overlap syndromes
- 3 Incidental splenomegaly: an approach to diagnosis
- 4 When to do a bone marrow biopsy and how to interpret it in the diagnosis of myeloproliferative neoplasm
- 5 Accurately assessing risk in your myeloproliferative neoplasm patient
- 6 Incorporating symptomatic assessment in therapy choice for patients with myeloproliferative neoplasms
- 7 The newly diagnosed patient with essential thrombocythemia
- 8 The newly diagnosed patient with polycythemia vera
- 9 Longstanding polycythemia vera and essential thrombocythemia: monitoring and management goals
- 10 Which patients are candidates for JAK inhibitors and how to manage patients on JAK inhibitor treatment
- 11 Hematopoietic cell transplantation for myelofibrosis: who and when?
- 12 Systemic mast cell disease: diagnosis and management
- 13 Hypereosinophilia: an illustrated approach to diagnosis and management
- 14 Myelodysplastic/myeloproliferative neoplasm overlap syndromes
- 15 Atypical chronic myeloid leukemia and chronic neutrophilic leukemia
- 16 Women and children with myeloproliferative neoplasms – special considerations
- 17 Conception and pregnancy in myeloproliferative neoplasms
- 18 Managing acute vascular events in patients with myeloproliferative neoplasms
- 19 Challenging thrombotic scenarios in the myeloproliferative neoplasms: splanchnic vein thrombosis and others
- 20 Familial myeloproliferative neoplasms – implications for patients and their families
- 21 Management of acute leukemia following myeloproliferative neoplasms
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Managing Myeloproliferative NeoplasmsA Case-Based Approach, pp. 17 - 21Publisher: Cambridge University PressPrint publication year: 2016
References
McIntyre, OR, Ebaugh, FG. Palpable spleens in college freshmen. Ann Intern Med. 1967;66(2):301–6.CrossRefGoogle ScholarPubMed
Ebaugh, FG, Jr., McIntyre, OR. Palpable spleens: ten-year follow-up. Ann Intern Med. 1979;90(1):130–1.CrossRefGoogle ScholarPubMed
Robertson, F, Leander, P, Ekberg, O. Radiology of the spleen. Eur Radiol. 2001;11:80–95.CrossRefGoogle ScholarPubMed
Beutler, E, Lichtman, MA, Coller, BS, et al. Williams Hematology, 6th edn. USA: McGraw Hill, p. 684.Google Scholar
Cesta, MF. Normal structure, function, and histology of the spleen. Toxicol Pathol. 2006;34(5):455–65.Google ScholarPubMed
Bolognesi, M, Merkel, C, Sacerdoti, D, et al. Role of spleen enlargement in cirrhosis with portal hypertension. Digest Liver Dis. 2002;34: 144–50.CrossRefGoogle ScholarPubMed
Tincani, E, Cioni, G, D’Alimonte, P, et al. Value of the measurement of portal flow velocity in the differential diagnosis of asymptomatic splenomegaly. Clin Radiol. 1997;52(3):220–3.CrossRefGoogle ScholarPubMed
Peck-Radosavljevic, M, Zacherl, J, Meng, Y, et al. Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol. 1997;27:127–31.Google Scholar
Gielchinsky, Y, Elstein, D, Hadas-Halpern, I, et al. Is there a correlation between degree of splenomegaly, symptoms and hypersplenism? A study of 218 patients with Gaucher disease. Br J Haematol. 1999;106(3):812–16.CrossRefGoogle Scholar
Tam, A, Krishnamurthy, S, Pillsbury, EP, et al. Percutaneous image-guided splenic biopsy in the oncology patient: an audit of 156 consecutive cases. J Vasc Interv Radiol. 2008;19(1):80–7.CrossRefGoogle ScholarPubMed
Zeppa, P, Picardi, M, Marino, G, et al. Fine-needle aspiration biopsy and flow cytometry immunophenotyping of lymphoid and myeloproliferative disorders of the spleen. Cancer. 2003;99(2):118–27.Google ScholarPubMed
Friedlander, MA, Wei, XJ, Iyengar, P, et al. Diagnostic pitfalls in fine needle aspiration biopsy of the spleen. Diagn Cytopathol. 2008;36(2):69–75.CrossRefGoogle ScholarPubMed
Liang, P, Gao, Y, Wang, Y, et al. US-guided percutaneous needle biopsy of the spleen using 18-gauge versus 21-gauge needles. J Clin Ultrasound. 2007;35(9):477–82.CrossRefGoogle ScholarPubMed
Hermann, RE, De Haven, KE, Hawk, WA. Splenectomy for the diagnosis of splenomegaly. Ann Surg. 1968;168(5):896–900.CrossRefGoogle ScholarPubMed
Kraus, MD, Fleming, MD, Vonderheide, RH. The spleen as a diagnostic specimen. Cancer. 2001;91(11):2001–9.3.0.CO;2-3>CrossRefGoogle ScholarPubMed